HealthEquity (NASDAQ:HQY) Releases FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.570-3.740 for the period, compared to the consensus earnings per share estimate of 3.760. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

HealthEquity Stock Performance

NASDAQ HQY opened at $101.67 on Wednesday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.81 billion, a price-to-earnings ratio of 93.28, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The business has a 50-day moving average price of $105.82 and a 200-day moving average price of $95.67.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HQY. Barrington Research reaffirmed an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Raymond James increased their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Wells Fargo & Company increased their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Mizuho began coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Finally, Royal Bank of Canada increased their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $112.92.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.